Back to Authors

Rex, Douglas K

0000-0002-9836-4309

Mayo Clinic

Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Citations 1

Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy: A Systematic Review and Meta-Analysis
Beran, Azizullah , Nayfeh, Tarek , Ramai, Daryl , Mohamed, Mouhand , Guardiola, John , Al‐Haddad, Mohammad , Rex, Douglas K. , Mohamed, Mouhand F H , Guardiola, John J , Al-Haddad, Mohammad , Rex, Douglas K , Nayfeh, Tarek , Akhras, Aya

American Journal of Gastroenterology | February 11, 2025 | Volume: 120 | Issue: 7 | Pages: 1653-1656

10.14309/ajg.0000000000003362 Get It

INTRODUCTION: The impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on colonoscopy bowel preparation is unclear. METHODS: We searched multiple databases for studies comparing bowel preparation quality between GLP-1RA users and the control group. Using a random-effects model, we calculated pooled odds ratios and mean differences with 95% confidence intervals (CIs). Inadequate bowel preparation (IBP) rate was the primary outcome, and Boston Bowel Preparation Scale mean score was the secondary outcome. RESULTS: Five studies with 10,833 patients (n = 5,434 GLP-1RAs vs n = 5,399 control) were included. The IBP rate was higher in the GLP-1RAs group compared with the control group (odds ratios 2.10, 95% CI 1.41–3.13, P = 0.0003). Furthermore, the mean Boston Bowel Preparation Scale score was lower in the GLP1-RAs group compared with the control group (mean differences −0.34; 95% CI −0.51, −0.17; P = 0.0001). DISCUSSION: Our findings suggest that using GLP-1RA increases the risk of IBP.